Lioresal 10 Tablet contains Baclofen 10 mg, a centrally acting skeletal muscle relaxant primarily indicated for the management of spasticity associated with multiple sclerosis, spinal cord injuries, and other neurological disorders. Baclofen exerts its therapeutic effect by stimulating GABA-B receptors in the spinal cord, leading to inhibition of monosynaptic and polysynaptic reflexes, thereby reducing muscle spasticity and improving mobility. Lioresal 10 is prescribed to alleviate symptoms such as muscle stiffness, spasms, and pain, enhancing patient comfort and functional ability. The tablet formulation allows for convenient oral administration, with dosing individualized based on clinical response and tolerability. Common adverse effects may include drowsiness, dizziness, weakness, and gastrointestinal disturbances, which generally diminish with continued use. Caution is advised in patients with renal impairment or those receiving other central nervous system depressants. Abrupt discontinuation should be avoided to prevent withdrawal symptoms such as increased spasticity, hallucinations, or seizures. Lioresal 10 should be used under medical supervision, with careful titration to achieve optimal therapeutic outcomes while minimizing side effects. Regular monitoring is recommended to assess efficacy and safety during treatment.